Model
Edge
CRISPR Therapeutics
0001968317
Filing Type
4
Filing Date
3/16/2026
Updated
3/17/26, 3:37 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership